Search by Drug Name or NDC
NDC 59148-0040-13 Rexulti 4 mg/1 Details
Rexulti 4 mg/1
Rexulti is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Otsuka America Pharmaceutical, Inc.. The primary component is BREXPIPRAZOLE.
MedlinePlus Drug Summary
Brexpiprazole is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions) in adults and children 13 years of age and older. It is also used with an antidepressant to treat depression when symptoms cannot be controlled by the antidepressant alone. Brexpiprazole is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.
Related Packages: 59148-0040-13Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Brexpiprazole
Product Information
| NDC | 59148-0040 |
|---|---|
| Product ID | 59148-040_57cc61f4-a0f8-46c1-a328-9605180f266e |
| Associated GPIs | 59250020000360 |
| GCN Sequence Number | 074448 |
| GCN Sequence Number Description | brexpiprazole TABLET 4 MG ORAL |
| HIC3 | H7X |
| HIC3 Description | ANTIPSYCHOTICS, ATYP, D2 PARTIAL AGONIST/5HT MIXED |
| GCN | 38619 |
| HICL Sequence Number | 042283 |
| HICL Sequence Number Description | BREXPIPRAZOLE |
| Brand/Generic | Brand |
| Proprietary Name | Rexulti |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | brexpiprazole |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 4 |
| Active Ingredient Units | mg/1 |
| Substance Name | BREXPIPRAZOLE |
| Labeler Name | Otsuka America Pharmaceutical, Inc. |
| Pharmaceutical Class | Atypical Antipsychotic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA205422 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 59148-0040-13 (59148004013)
| NDC Package Code | 59148-040-13 |
|---|---|
| Billing NDC | 59148004013 |
| Package | 1 BOTTLE in 1 CARTON (59148-040-13) / 30 TABLET in 1 BOTTLE |
| Marketing Start Date | 2015-07-10 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 47.0266 |
| Pricing Unit | EA |
| Effective Date | 2024-01-15 |
| NDC Description | REXULTI 4 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis